Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,439 | 73 | 94.8% |
| Education | $78.99 | 1 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $522.99 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $288.34 | 15 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $223.00 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $99.58 | 6 | $0 (2024) |
| Amgen Inc. | $83.21 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $67.73 | 3 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $53.99 | 4 | $0 (2024) |
| Lilly USA, LLC | $39.27 | 2 | $0 (2024) |
| Vifor Pharma, Inc. | $33.87 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.20 | 24 | AstraZeneca Pharmaceuticals LP ($193.66) |
| 2023 | $871.18 | 42 | AstraZeneca Pharmaceuticals LP ($312.23) |
| 2022 | $121.50 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($42.34) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.21 | General |
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Nephrology | ||||||
| 10/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.90 | General |
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEPHROLOGY | ||||||
| 09/04/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Catheter Lock Solution | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 06/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 05/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEPHROLOGY | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Nephrology | ||||||
| 02/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: DIABETES | ||||||
| 01/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardio-renal | ||||||
| 01/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/05/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $91.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 486 | 776 | $133,065 | $54,213 |
| 2022 | 4 | 108 | 139 | $22,235 | $10,682 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 349 | $59,595 | $26,576 | 44.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 75 | 205 | $32,800 | $9,707 | 29.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 69 | 69 | $20,990 | $9,556 | 45.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $9,560 | $4,074 | 42.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 21 | 42 | $6,300 | $2,353 | 37.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 34 | $3,400 | $1,806 | 53.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 42 | 42 | $420.00 | $139.81 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 73 | $11,315 | $6,247 | 55.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,480 | $1,814 | 52.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 12 | 34 | $5,440 | $1,665 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 20 | $2,000 | $956.20 | 47.8% |
About Heidi Odum, APRN
Heidi Odum, APRN is a Nurse Practitioner healthcare provider based in Manchester, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2022. The National Provider Identifier (NPI) number assigned to this provider is 1730814260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heidi Odum, APRN has received a total of $1,518 in payments from pharmaceutical and medical device companies, with $525.20 received in 2024. These payments were reported across 74 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,439).
As a Medicare-enrolled provider, Odum has provided services to 594 Medicare beneficiaries, totaling 915 services with total Medicare billing of $64,895. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nephrology
- Location Manchester, NH
- Active Since 07/19/2022
- Last Updated 01/05/2026
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1730814260
Products in Payments
- FARXIGA (Drug) $378.55
- Kerendia (Drug) $288.34
- ACTHAR (Biological) $223.00
- LOKELMA (Drug) $144.44
- JYNARQUE (Drug) $99.58
- JARDIANCE (Drug) $57.51
- TAVNEOS (Drug) $40.16
- Velphoro (Drug) $39.17
- Veltassa (Drug) $33.87
- Aranesp (Biological) $15.55
- FABRAZYME (Biological) $15.17
- Auryxia (Drug) $15.07
- DefenCath (Drug) $14.70
- KRYSTEXXA (Biological) $13.82
- Parsabiv (Drug) $13.68
- BENLYSTA (Biological) $13.01
- TARPEYO (Drug) $12.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Manchester
Megan Carlucci, Aprn, APRN
Nurse Practitioner — Payments: $19,930
Scott Chastek, Crna / Arnp, CRNA / ARNP
Nurse Practitioner — Payments: $1,960
Paul Arnstein, Arnp, ARNP
Nurse Practitioner — Payments: $1,710
Victoria Schmelzer
Nurse Practitioner — Payments: $1,597
Mrs. Candice Kusch, Np, NP
Nurse Practitioner — Payments: $1,419
Marilyn Daley, Np, NP
Nurse Practitioner — Payments: $1,202